Water molecules inside protein structure affect binding of monosaccharides with HIV-1 antibody 2G12

2016 ◽  
Vol 37 (26) ◽  
pp. 2341-2348 ◽  
Author(s):  
Kaori Ueno-Noto ◽  
Keiko Takano
Author(s):  
Arry Yanuar ◽  
Rezi Riadhi Syahdi ◽  
Widya Dwi Aryati

Objective: Human immunodeficiency virus (HIV-1) is a virus that causes acquired immunodeficiency syndrome, a disease considered to be one of themost dangerous because of its high mortality, morbidity, and infectivity. The emergence of mutant HIV strains has led treatment to target proteaseas reverse transcriptase and integrase enzyme become less effective. This study aims to provide knowledge about the potential of HIV-1 integraseinhibitors for use as guiding compounds in the development of new anti-HIV drugs.Methods: This study used AutoDock and AutoDock Vina for virtual screening of the Indonesian herbal database for inhibitors of HIV-1 integrase andis validated using a database of the directory of useful decoys. Optimization was accomplished by selecting the grid size, the number of calculations,and the addition of two water molecules and a magnesium atom as cofactor.Results: This study determined that the best grid box size is 21.1725×21.1725×21.1725 in unit space size (1 unit space equals to macromolecules 1Ǻ),using AutoDock Vina with EF and AUC values, 3.93 and 0.693, respectively. Three important water molecules have meaning in molecular dockingaround the binding pocket.Conclusions: This study obtained the top ten ranked compounds using AutoDock Vina. The compounds include: Casuarinin; Myricetin-3-O-(2’’,6’’-di-O-α-rhamnosyl)-β-glucoside; 5,7,2’,4’-tetrahydroxy-6,3’-diprenylisoflavone 5-O-(4’’-rhamnosylrhamnoside); myricetin 3-robinobioside; cyanidin3-[6-(6-ferulylglucosyl)-2-xylosylgalactoside]; mesuein, cyanidin 7-(3-glucosyl-6-malonylglucoside)-4’-glucoside; kaempferol 3-[glucosyl-(1→3)-rhamnosyl-(1→6)-galactoside]; 3-O-galloylepicatechin-(4-β→8)-epicatechin-3-O-gallate; and quercetin 4’-glucuronide.


2011 ◽  
Vol 410 (5) ◽  
pp. 798-810 ◽  
Author(s):  
Marco Marradi ◽  
Paolo Di Gianvincenzo ◽  
Pedro M. Enríquez-Navas ◽  
Olga M. Martínez-Ávila ◽  
Fabrizio Chiodo ◽  
...  

Cell Reports ◽  
2013 ◽  
Vol 5 (5) ◽  
pp. 1443-1455 ◽  
Author(s):  
Yunji Wu ◽  
Anthony P. West ◽  
Helen J. Kim ◽  
Matthew E. Thornton ◽  
Andrew B. Ward ◽  
...  

Virology ◽  
2007 ◽  
Vol 360 (2) ◽  
pp. 294-304 ◽  
Author(s):  
Dana Huskens ◽  
Kristel Van Laethem ◽  
Kurt Vermeire ◽  
Jan Balzarini ◽  
Dominique Schols
Keyword(s):  
Hiv 1 ◽  

ChemInform ◽  
2010 ◽  
Vol 27 (43) ◽  
pp. no-no
Author(s):  
M. MELNICK ◽  
S. H. REICH ◽  
K. K. LEWIS ◽  
L. J. JUN. MITCHELL ◽  
NGUYEN DZUY NGUYEN DZUY ◽  
...  

2015 ◽  
Vol 12 (111) ◽  
pp. 20150579 ◽  
Author(s):  
Austin G. Meyer ◽  
Claus O. Wilke

Protein structure acts as a general constraint on the evolution of viral proteins. One widely recognized structural constraint explaining evolutionary variation among sites is the relative solvent accessibility (RSA) of residues in the folded protein. In influenza virus, the distance from functional sites has been found to explain an additional portion of the evolutionary variation in the external antigenic proteins. However, to what extent RSA and distance from a reference site in the protein can be used more generally to explain protein adaptation in other viruses and in the different proteins of any given virus remains an open question. To address this question, we have carried out an analysis of the distribution and structural predictors of site-wise d N /d S in HIV-1. Our results indicate that the distribution of d N /d S in HIV follows a smooth gamma distribution, with no special enrichment or depletion of sites with d N /d S at or above one. The variation in d N /d S can be partially explained by RSA and distance from a reference site in the protein, but these structural constraints do not act uniformly among the different HIV-1 proteins. Structural constraints are highly predictive in just one of the three enzymes and one of three structural proteins in HIV-1. For these two proteins, the protease enzyme and the gp120 structural protein, structure explains between 30 and 40% of the variation in d N /d S . Finally, for the gp120 protein of the receptor-binding complex, we also find that glycosylation sites explain just 2% of the variation in d N /d S and do not explain gp120 evolution independently of either RSA or distance from the apical surface.


2010 ◽  
Vol 84 (20) ◽  
pp. 10690-10699 ◽  
Author(s):  
Katie J. Doores ◽  
Zara Fulton ◽  
Michael Huber ◽  
Ian A. Wilson ◽  
Dennis R. Burton

ABSTRACT The broadly neutralizing anti-human immunodeficiency virus type 1 (HIV-1) antibody 2G12 targets the high-mannose cluster on the glycan shield of HIV-1. 2G12 has a unique VH domain-exchanged structure, with a multivalent binding surface that includes two primary glycan binding sites. The high-mannose cluster is an attractive target for HIV-1 vaccine design, but so far, no carbohydrate immunogen has elicited 2G12-like antibodies. Important questions remain as to how this domain exchange arose in 2G12 and how this unusual event conferred unexpected reactivity against the glycan shield of HIV-1. In order to address these questions, we generated a nondomain-exchanged variant of 2G12 to produce a conventional Y/T-shaped antibody through a single amino acid substitution (2G12 I19R) and showed that, as for the 2G12 wild type (2G12 WT), this antibody is able to recognize the same Manα1,2Man motif on recombinant gp120, Candida albicans, and synthetic glycoconjugates. However, the nondomain-exchanged variant of 2G12 is unable to bind the cluster of mannose moieties on the surface of HIV-1. Crystallographic analysis of 2G12 I19R in complex with Manα1,2Man revealed an adaptable hinge between VH and CH1 that enables the VH and VL domains to assemble in such a way that the configuration of the primary binding site and its interaction with disaccharide are remarkably similar in the nondomain-exchanged and domain-exchanged forms. Together with data that suggest that very few substitutions are required for domain exchange, the results suggest potential mechanisms for the evolution of domain-exchanged antibodies and immunization strategies for eliciting such antibodies.


Sign in / Sign up

Export Citation Format

Share Document